We are a nation of phone lovers but there have been worries in the past that our devices could actually be harming us ...

A World Health Organization (WHO)-commissioned systematic review published in Environment International finds no association ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Panelists discuss the findings from the POLARIX study, focusing on the efficacy and safety of polatuzumab vedotin in combination with rituximab and chemotherapy for untreated diffuse large B-cell ...

Researchers project that 618,120 people will die from cancer in the US this year, which works out to about 1700 deaths per day. The American Cancer Society (ACS) has released cancer statistics for ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, when a causative role of the drug is implausible, suggested stepped-up ...

It may be a sign of a serious medical problem. The most common cause of bulging eyes is hyperthyroidism, or an overactive thyroid gland. The thyroid gland is located in the front of your neck and ...

In 24 of 30 patients with lymphoma of the thyroid, the diagnosis was made preoperatively or without surgery; undifferentiated or poorly differentiated carcinoma was suspected in 3 other patients.

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment. Patients with lymphoma or leukemia involving the ...

Lymphoma is staged based on where in the body ... endocrine disorders such as diabetes and thyroid conditions, and more. Yun has a bachelor’s degree in biochemistry and molecular biology from ...

The Food and Drug Administration (FDA) has granted traditional approval to Calquence (acalabrutinib) with bendamustine and Rituxan (rituximab) for adults with previously untreated mantle cell lymphoma ...